ArticleNature communications2021

A single dose of ChAdOx1 Chik vaccine induces neutralizing antibodies against four chikungunya virus lineages in a phase 1 clinical trial.

Pedro M Folegatti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.